Immune evasion might affect survival in laryngeal cancer patients with blood group O

by Kadri Altundag
Published 2017-07-01

Increased pathologic complete response are expected in HER2-positive and triple-negative locally advanced breast cancers

by Kadri Altundag
Published 2017-05-01

Current and emerging treatment options in triple-negative breast cancer

by Omer Dizdar, Kadri Altundag
Published 2011-12-01

Serum endocan level and its prognostic significance in breast cancer patients

by Ozturk Ates, Emre Gedik, Veli Sunar, Kadri Altundag
Published 2018-04-01

Synchronous presentation of nasopharyngeal and renal cell carcinomas

by Cem Boruban, Ozlem Yavas, Kadri Altundag, Orhan Sencan
Published 2006-06-01

Efficacy of Palbociclib and Endocrine Treatment in Heavily Pretreated Hormone Receptor-positive/HER2-negative Advanced Breast Cancer: Retrospective Multicenter Trial

by Atakan Demir, Nil Molinas Mandel, Semra Paydas, Gökhan Demir, Özlem Er, Nazım Serdal Turhal, Sevil Bavbek, Yeşim Eralp, Pınar Mualla Saip, Emine Nilüfer Güler, Adnan Aydıner, Başak Oyan Uluç, Sadettin Kılıçkap, Necdet Üskent, Nuri Karadurmuş, Mehmet Ali Kaplan, Mustafa Teoman Yanmaz, Hacer Demir, Özkan Alan, Taner Korkmaz, Polat Olgun, Özlem Sönmez Uysal, Kadri Altundağ, Şeyda Gündüz, Meral Günaldı, Murat Sarı, İsmail Beypınar, Gül Başaran
Published 2020-03-01